Related Experiment Video

Updated: Jun 29, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Is an invasive interventional strategy of value in non-ST-elevation acute coronary syndromes?

William S Weintraub1

  • 1Christiana Care Health System, Newark, DE 19718, USA. wweintraub@christianacare.org

Nature Clinical Practice. Cardiovascular Medicine
|October 8, 2008
PubMed

Insights

An invasive strategy is cost-effective for high-risk patients with non-ST-elevation acute coronary syndromes, but not for low-risk patients. Intermediate-risk patients showed equivocal results, suggesting tailored treatment approaches.

Area of Science:

  • Cardiology
  • Health Economics

Background:

  • Cost-effectiveness analysis is crucial for evaluating therapeutic value in acute coronary syndromes.
  • Non-ST-elevation acute coronary syndromes (NSTE-ACS) require careful consideration of invasive versus conservative management strategies.

Purpose of the Study:

  • To assess the cost-effectiveness of an invasive strategy in patients with NSTE-ACS.
  • To determine risk stratification for optimal resource allocation in NSTE-ACS management.

Main Methods:

  • Economic analysis utilizing data from the RITA 3 trial.
  • Comparison of invasive strategy cost-effectiveness across different patient risk strata (low, intermediate, high).

Main Results:

  • An invasive strategy was not cost-effective for low-risk NSTE-ACS patients.
  • Cost-effectiveness was demonstrated for high-risk NSTE-ACS patients.
  • Equivocal cost-effectiveness was observed in intermediate-risk NSTE-ACS patients.

Conclusions:

  • An invasive strategy is recommended for high-risk NSTE-ACS patients.
  • Risk stratification is essential for guiding cost-effective treatment decisions in NSTE-ACS.
  • Further trials may face ethical and logistical challenges despite evolving technology.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...